Improving the solubility of 6-mercaptopurine via cocrystals and salts

  • Xu L
  • Chen J
  • Yan Y
 et al. 
  • 17


    Mendeley users who have this article in their library.
  • 23


    Citations of this article.


An antitumor drug, 6-mercaptopurine monohydrate, has a low oral bioavailability (about 16%) due to its poor aqueous solubility. To improve its solubility, two cocrystals of 6-mercaptopurine with 4-hydroxybenzoic acid (1) and 2,4-dihydroxybenzoic acid (2), as well as two salts with piperazine in 1:1 (3) and 2:1 (4) stoichiometry, respectively, were obtained and characterized by infrared spectra, powder and single crystal X-ray diffraction. The structures of 1-4 are assembled via N-H(pyrimidine)•O(carboxyl), N-H(pyrimidine) •N(imidazole), O-H(carboxyl)•S, O-H(hydroxyl)•N(imidazole), N-H(pyrimidine)•S, O-H(carboxyl)•O(carboxyl) and N-H(piperazine) •N(imidazole) hydrogen bonds. After the formation of cocrystals and salts, the solubility of 6-mercaptopurine monohydrate is much improved, and the apparent solubility values of 1-4 in the phosphate buffer of pH 6.8 are approximately 1.6, 2.0, 14.0, and 4.2 times as large as that of 6-mercaptopurine monohydrate. Interestingly, 3 transformed to 4 at 40 °C/75% RH within one month. © 2012 American Chemical Society.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • Lin Lin Xu

  • Jia Mei Chen

  • Yan Yan

  • Tong Bu Lu

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free